Five Biotech Milestones – Lab to Success
Developing a molecule from lab to patients requires more than 1,000 decisions, made right and at the right time. However, the […]
Capabilities
Targeting the Totality of MS: Jason Tardio on Immunic’s Combined Neuroprotective & Anti-Inflammatory Strategy
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Jason Tardio, President and
The Future of Psychedelic Medicine: Clinical Strategy and Scaling Access.
Welcome to a special edition of IDEA Collider’s “Deep Medicine” series. In this episode, host Alex Gray sits down with
The Power of the Early Narrative: Sue Wood on Strategic Biotech Positioning
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Sue Wood, a senior
The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray is joined by IDEA Pharma colleagues David Radwaner and
The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray, Chief Medical and Innovation Officer at IDEA Pharma, is
Eli Lilly top 2026 Global Pharmaceutical Innovation & Invention Index
Eli Lilly First Ever Company to Top Both Rankings in the 2026 Pharmaceutical Innovation and Invention Index See the full results at https://www.ideapharma.com/pii/report/global/ LONDON, UK — May 19th 2026 — The 2026 Global Pharmaceutical Innovation
IDEA Pharma is a proud partner of Candel Therapeutics
Through an integrated partnership with EVERSANA and CANDEL, we are helping to change patient lives by maximizing the potential of aglatimagene besadenovec to raise the standards
The Evolving World of Social & Digital Media Intelligence
It is no secret that social media is an essential channel for expressing opinions and sharing facts. Depicted through visual representations and the written word, the world works fundamentally through online channels, without which we would be thrown back into a rudimentary and non-progressive lifestyle.
Challenges in Hemoglobinopathies Projects and the Support of KOL Match
There are over 7,000 rare diseases described, affecting about 20-30 million people in the U.S. alone, according to the NIH. While each condition has its specificities, there are common challenges in the rare disease space, such as finding patients and leveraging centers of excellence and referral networks. This article discusses such challenges and how partnering with SAI’s subject matter experts can help overcome them.